Reference Pricing — Coming soon to a health plan near you?

There is great interest in reference pricing in the US for select medical procedures and branded drugs. While only 10% of mid-sized and large employers are utilizing reference pricing, more than 2/3 of employers have an interest in this payment technique. If it takes hold, there is a potential impact on utilization, revenue and quality of care that manufacturers will need to address.

MedSpan Research Pay-For-Performance Case Study

MedSpan Research Pay-For-Performance Case Study http://wp.me/pReqv-m:

Connectivity is one of the Key Underlying P4P Programs…Read more to learn why

Managed Care Musings-Tips for better payer research

Managed Care Musings-Tips for better payer research

MedSpan Research’s Managed Markets Perspectives

MedSpan Research’s Managed Markets Perspectives: Pay For Performance Programs are becoming more prevalent. Dialysis facilities are already using this type of reimbursement program to improve on quality measures.

Here’s a MedSpan Research tip!

Clinical pharmacists are a good deal for drug companies’ market research. Consider clinical pharmacists as respondents when needing clinical insights regarding a new drug. Remember that health plan and some hospital-based clinical pharmacists specialize by drug class. Other hospital-based clinical pharmacists specialize by patient care unit (e.g., emergency department, ICU).